Vecuronium Bromide Injection Generics Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for reconstitution- IV use
Available Strengths: 10 mg/vial, 20 mg/vial
Reference Brands: Norcuron® (EU & US)
Category:
Anaesthetics
Vecuronium Bromide Injection is a neuromuscular blocker used for intubation and muscle relaxation during surgery, available as a 10 mg or 20 mg lyophilized powder for IV use. Approved in both the US and EU.
Vecuronium Bromide Injection Generics is available in Lyophilized powder for reconstitution- IV use
and strengths such as 10 mg/vial, 20 mg/vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vecuronium Bromide Injection Generics is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vecuronium Bromide Injection Generics can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vecuronium Bromide Injection is a non-depolarizing neuromuscular blocking agent used to facilitate endotracheal intubation and provide skeletal muscle relaxation during surgery or mechanical ventilation. Supplied as a lyophilized powder (typically 10 mg or 20 mg per vial), it is reconstituted for intravenous use. With rapid onset and intermediate duration, it is a trusted choice in both surgical and critical care settings. Approved by the FDA and EMA, Vecuronium is marketed under brand names like Norcuron® and various generics in the US and EU. Ideal for B2B partners, tenders, and hospital supply chains across regulated markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing